Femtobiomed Inc. (XKON: 327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,490.00
+520.00 (10.46%)
Jan 20, 2025, 9:00 AM KST
-1.79%
Market Cap 47.17B
Revenue n/a
Net Income n/a
Shares Out 8.26M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,672
Average Volume 6,584
Open 4,820.00
Previous Close 4,970.00
Day's Range 4,820.00 - 5,600.00
52-Week Range 4,510.00 - 10,790.00
Beta 0.95
RSI 56.99
Earnings Date n/a

About Femtobiomed

Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile

News

There is no news available yet.